Vasarya Therapeutics, Inc.

Biotechnology company · Camden, Delaware, United States

Vasarya Therapeutics, Inc. is a biotechnology company headquartered in Camden, Delaware, United States. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $1.8 million in total, most recently in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Vasarya Therapeutics at a glance

Typebiotechnology company

HeadquartersCamden, Delaware, United States

Employees (self-reported, 2025)4

What does Vasarya Therapeutics do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $1.8 million in total (2024 to 2025). NIH funding came from the National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases.

Frequently asked questions about Vasarya Therapeutics

Where is Vasarya Therapeutics headquartered?

Vasarya Therapeutics, Inc. is headquartered in Camden, Delaware, United States.

What does Vasarya Therapeutics do?

Vasarya Therapeutics, Inc. is a biotechnology company.

Similar companies

Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Cognition Therapeutics IncPurchase, New York, United States
Agenus IncLexington, Massachusetts, United States
Vaxcyte, Inc.San Carlos, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences